Mechanistically, Wang et al. proposed a PSMB4/NF-κB signaling pathway in breast cancer, suggesting that siRNA gene silencing of PSMB4 decreased NF-κB activity and cell viability, and caused cell cycle arrest at the G1/S phase 58. This evidence concerns the gene NFKB1 and breast cancer.